Video

Resilience Capacity Update May 2024: Cell & Gene Therapy

Resilience is excited to participate and provide an overview of Cell & Gene Therapy Capabilities at our prominent North America sites. Founded in 2020, Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. With a strong network of 11 sites located across North America supporting 5 modalities from development through commercial manufacturing, Resilience provides innovative solutions and services for established and emerging therapies. Hear from Eytan Abraham, Business Head of Cell Therapy, Gene Therapy & Nucleic Acids, and learn about how Resilience can support your development and manufacturing programs.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Resilience US, Inc.